AURA Logo

Aura Biosciences, Inc. (AURA) 

NASDAQ
Market Cap
$441.07M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
559 of 966
Rank in Industry
305 of 554

Largest Insider Buys in Sector

AURA Stock Price History Chart

AURA Stock Performance

About Aura Biosciences, Inc.

Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develops AU-011 in additional ocular oncology indications, including choroidal metastases. The company was incorporated in 2009 and is headquartered in Cambridge, Massachusetts.

Insider Activity of Aura Biosciences, Inc.

Over the last 12 months, insiders at Aura Biosciences, Inc. have bought $0 and sold $1.06M worth of Aura Biosciences, Inc. stock.

On average, over the past 5 years, insiders at Aura Biosciences, Inc. have bought $21.79M and sold $473,027 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 1,560,000 shares for transaction amount of $14.04M was made by Matrix Capital Management Company, LP (10 percent owner) on 2023‑11‑09.

List of Insider Buy and Sell Transactions, Aura Biosciences, Inc.

2024-11-18SaleChief Medical Officer
11,822
0.0244%
$9.36$110,663-2.36%
2024-10-29SaleSee Remarks
9,200
0.0186%
$10.74$98,788-13.07%
2024-10-29SaleVice President, Finance
553
0.0011%
$10.74$5,938-13.07%
2024-10-18SaleSee Remarks
24,992
0.0517%
$12.04$300,839-19.34%
2024-10-18SaleChief Financial Officer
25,131
0.0519%
$12.03$302,361-19.34%
2024-10-16SaleChief Technology Officer
7,383
0.0163%
$9.85$72,723-0.98%
2024-01-23SaleSee Remarks
15,853
0.0323%
$7.64$121,141+4.64%
2024-01-23SaleChief Financial Officer
6,609
0.0135%
$7.64$50,521+4.64%
2023-11-09Purchase10 percent owner
1.56M
5.251%
$9.00$14.04M+14.06%
2023-11-08Purchasedirector
19,601
0.0517%
$7.30$143,087+11.46%
2023-11-07Purchasedirector
123,000
0.3185%
$7.17$881,910+12.73%
2023-11-06SaleSee Remarks
7,449
0.0211%
$12.03$89,611-28.10%
2023-11-06SaleChief Financial Officer
3,900
0.0111%
$12.07$47,054-28.10%
2023-10-30SaleSee Remarks
9,586
0.0229%
$6.83$65,478+7.23%
2023-10-30SaleChief Financial Officer
3,385
0.0081%
$6.82$23,091+7.23%
2023-10-04Purchasedirector
6,566
0.0178%
$8.61$56,512-7.88%
2023-10-03Purchasedirector
13,500
0.0352%
$8.27$111,663-6.59%
2023-01-06Purchasedirector
904
0.0024%
$10.51$9,501-3.81%
2023-01-05Purchasedirector
396
0.001%
$10.00$3,960-2.60%
2022-12-28Purchasedirector
2,000
0.0066%
$9.75$19,500+3.45%

Insider Historical Profitability

<0.0001%
de los Pinos ElisabetSee Remarks
320647
0.6419%
$8.8306
Hopkins Janet JillChief Medical Officer
151693
0.3037%
$8.8301
Feder Julie BChief Financial Officer
134276
0.2688%
$8.8305
Plavsic MarkChief Technology Officer
121132
0.2425%
$8.8301
Elazzouzi AmyVice President, Finance
39443
0.079%
$8.8301
Matrix Capital Management Company, LP10 percent owner
6922870
13.8592%
$8.8330<0.0001%
Medicxi Ventures Management (Jersey) Ltddirector
2969352
5.9445%
$8.8310<0.0001%
Johnson David Michaeldirector
135667
0.2716%
$8.8390<0.0001%
Rich CadmusSee Remarks
24578
0.0492%
$8.8301
De Rosch MarkChief Operating Officer
16385
0.0328%
$8.8301

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Matrix Capital Management Company, L.P.$54.34M13.976.92M0%+$00.51
Eventide Asset Management$45.55M11.715.8M0%+$00.74
Adage Capital Partners Gp L L C$35.05M9.014.46M+5.68%+$1.88M0.06
Citadel Advisors LLC$28.86M7.423.68M+1.24%+$353,077.300.02
Medicxi Growth I Lp$23.86M6.143.04M0%+$05.31
BlackRock$19.19M4.932.44M+16.49%+$2.72M<0.0001
The Vanguard Group$13.25M3.411.69M-2.49%-$337,714.84<0.0001
Franklin Templeton Investments$11.41M2.931.45M+142.18%+$6.7M<0.01
Nantahala Capital Management Llc$10.38M2.671.32M0%+$00.48
Goldman Sachs$7.82M2.01996,643-3.92%-$319,149.62<0.01
Regency Capital Management Inc De$6.16M1.59785,136+11.37%+$629,271.744.01
Geode Capital Management$6.13M1.58781,190+15.54%+$824,861.98<0.01
T. Rowe Price$4.68M1.2595,540-9.72%-$503,702.11<0.01
State Street$4.47M1.15569,804+12.55%+$498,804.66<0.0001
Long Focus Capital Management Llc$3.89M1495,422+45.53%+$1.22M0.46
Ensign Peak Advisors Inc$2.8M0.72357,2220%+$00.01
Northern Trust$2.33M0.6296,323+19.28%+$375,952.27<0.0001
Fidelity Investments$2.31M0.6294,654-17.47%-$489,690.87<0.0001
Jefferies Financial Group$1.75M0.45222,497New+$1.75M0.03
Dimensional Fund Advisors$1.64M0.42208,664+17.41%+$242,926.04<0.0001
PLATINUM INVESTMENT MANAGEMENT LTD$1.41M0.36180,1450%+$00.02
Verition Fund Management Llc$1.19M0.31151,681-0.33%-$3,964.250.01
Two Sigma$894,029.000.23113,889+168.69%+$561,290.92<0.01
Levin Capital Strategies$872,920.000.22111,200+11.2%+$87,920.000.09
Td Asset Management Inc$847,109.000.22107,9120%+$0<0.01
Charles Schwab$834,015.000.21106,244+16.18%+$116,148.54<0.0001
D. E. Shaw & Co.$749,243.000.1995,445+58.91%+$277,740.76<0.01
BNY Mellon$741,651.000.1994,478+4.64%+$32,914.99<0.0001
Morgan Stanley$681,821.000.1886,856+4.94%+$32,098.72<0.0001
Connor Clark & Lunn Investment Management Ltd$562,735.000.1571,686+454.76%+$461,297.32<0.01
Millennium Management LLC$555,128.000.1470,717New+$555,128.00<0.0001
Nuveen$551,455.000.1470,2490%+$0<0.0001
Ubs Oconnor Llc$528,501.000.1467,325-25.19%-$177,998.670.02
TBH Global Asset Management$473,530.000.1260,3220%+$00.1
Renaissance Technologies$448,000.000.1257,100+100.35%+$224,392.29<0.01
The Manufacturers Life Insurance Company$441,625.000.1156,258+0.57%+$2,512.00<0.0001
New York Life Investment Management Llc$366,862.000.0946,734New+$366,862.00<0.01
RhumbLine Advisers$356,947.000.0945,472+14.01%+$43,872.64<0.0001
Exchange Traded Concepts, LLC$299,831.000.0838,195+156.36%+$182,873.750.01
Marshall Wace$292,083.000.0837,208New+$292,083.00<0.0001
UBS$287,671.000.0736,646+17.98%+$43,834.39<0.0001
Bank of America$274,224.000.0734,933-1.49%-$4,136.95<0.0001
Alps Advisors Inc$272,364.000.0734,696+3.08%+$8,132.61<0.01
Two Sigma Advisers LP$247,275.000.0631,500New+$247,275.00<0.0001
Values First Advisors, Inc.$214,232.000.0627,291+149.71%+$128,440.290.05
Barclays$199,000.000.0525,394-33.47%-$100,111.25<0.0001
JPMorgan Chase$190,636.000.0524,285+32.27%+$46,510.94<0.0001
Letko Brosseau$166,420.000.0421,200New+$166,420.00<0.01
Jane Street Capital$165,023.000.0421,022-26.97%-$60,955.36<0.0001
Susquehanna International Group$144,393.000.0418,394+69.91%+$59,408.84<0.0001
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.